miR-203 had a pivotal anti-oncogenic role in melanoma through reducing melanosome transport and promoting melanogenesis by targeting kif5b and through negative regulation of the CREB1/MITF/Rab27a pathway [17]. The gene discussed is RAB27A; the disease is melanoma.